Home > Share Market > Stocks > Neuland laboratories > Financial Statements > NEULANDLAB Key Financial Ratios

Neuland laboratories Financial Statements

Neuland laboratories Key Financial Ratios

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2019 Mar-2018
Growth matrix (%)        
Revenue growth 22.80 14.40 26.40 (8.90)
Op profit growth 44.10 74.60 15.70 (53)
EBIT growth 65.40 107 9.55 (63)
Net profit growth 397 (1.40) 36.30 (74)
Profitability ratios (%)        
OPM 15.70 13.40 8.75 9.56
EBIT margin 13.20 9.77 5.40 6.23
Net profit margin 8.61 2.13 2.47 2.29
RoCE 11.80 7.26 3.69 3.81
RoNW 2.69 0.58 0.65 0.55
RoA 1.94 0.39 0.42 0.35
Per share ratios ()        
EPS 62.50 12.60 12.70 13.50
Dividend per share 3 2 -- --
Cash EPS 31.90 (12) (7.30) (11)
Book value per share 613 553 542 623
Valuation ratios        
P/E 33.40 22.50 52.90 52.50
P/CEPS 65.40 (24) (92) (63)
P/B 3.41 0.51 1.24 1.13
EV/EBIDTA 17.40 5.49 17.10 16.90
Payout (%)        
Dividend payout -- -- -- --
Tax payout (23) (69) (19) (13)
Liquidity ratios        
Debtor days 79.40 84.70 98 130
Inventory days 91 98.60 101 107
Creditor days (67) (69) (77) (84)
Leverage ratios        
Interest coverage (6.90) (3.50) (2.30) (1.70)
Net debt / equity 0.21 0.31 0.28 0.54
Net debt / op. profit 1.11 2.13 3.32 5.99
Cost breakup ()        
Material costs (47) (50) (55) (45)
Employee costs (16) (16) (17) (20)
Other costs (22) (21) (20) (26)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000